Similar Articles
1011 Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development
1012 Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells
1013 Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet
1014 Strategies to increase the resectability of hepatocellular carcinoma
1015 Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma
1016 Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma
1017 Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma
1018 Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure
1019 Immunology of hepatocellular carcinoma
1020 Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA